Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Accenture
Merck
UBS
QuintilesIMS
Covington
Citi
Chinese Patent Office
Teva

Generated: April 27, 2018

DrugPatentWatch Database Preview

PROTAMINE ZINC INSULIN Drug Profile

« Back to Dashboard

When do Protamine Zinc Insulin patents expire, and what generic alternatives are available?

Protamine Zinc Insulin is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in PROTAMINE ZINC INSULIN is insulin susp protamine zinc purified beef. There are thirty-nine drug master file entries for this compound. Additional details are available on the insulin susp protamine zinc purified beef profile page.
Summary for PROTAMINE ZINC INSULIN
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 4,124
Drug Prices:see details
DailyMed Link:PROTAMINE ZINC INSULIN at DailyMed
Drug patent expirations by year for PROTAMINE ZINC INSULIN

US Patents and Regulatory Information for PROTAMINE ZINC INSULIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb PROTAMINE ZINC INSULIN insulin susp protamine zinc purified beef INJECTABLE;INJECTION 017928-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb PROTAMINE ZINC INSULIN insulin susp protamine zinc purified beef INJECTABLE;INJECTION 017928-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Johnson and Johnson
Medtronic
Julphar
Accenture
Cantor Fitzgerald
UBS
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.